Illumina, Inc.
ILMN
Kedudukan dalam Saham
#612
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis... Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
Harga Saham
$262.37
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$39.62B
Perubahan (1 hari)
-0.07%
Perubahan (1 tahun)
163.68%
Negara
US
Perdagangan Illumina, Inc. (ILMN)
Kategori
Healthcare
Nisbah P/B bagi Illumina, Inc. (ILMN)
Nisbah P/B pada October 2026 TTM: 14.46
Menurut laporan kewangan dan harga saham terkini Illumina, Inc., nisbah P/B semasa (TTM) ialah 14.46. Pada akhir 2024, nisbah P/B syarikat ialah 8.95.
Sejarah nisbah P/B untuk Illumina, Inc. dari 2000 hingga 2026
Nisbah P/B pada akhir setiap tahun
| Tahun | Nisbah P/B | Ubah |
|---|---|---|
| 2026 (TTM) | 14.46 | 96.19% |
| 2025 | 7.37 | -17.66% |
| 2024 | 8.95 | 140.48% |
| 2023 | 3.72 | -28.01% |
| 2022 | 5.17 | -53.81% |
| 2021 | 11.19 | 10.14% |
| 2019 | 10.16 | -8.81% |
| 2018 | 11.14 | 2.23% |
| 2017 | 10.90 | -21.12% |
| 2016 | 13.82 | -19.04% |
| 2014 | 17.07 | 95.36% |
| 2013 | 8.74 | 73.38% |
| 2012 | 5.04 | -21.90% |
| 2011 | 6.45 | 52.50% |
| 2010 | 4.23 | 27.27% |
| 2008 | 3.32 | -56.13% |
| 2007 | 7.58 | 10.25% |
| 2006 | 6.87 | 53.95% |
| 2005 | 4.46 | -5.60% |
| 2003 | 4.73 | 247.59% |
| 2002 | 1.36 | -57.23% |
| 2001 | 3.18 | -9.14% |
| 2000 | 3.50 | 0.00% |
Nisbah P/B untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/B | Perbezaan Nisbah P/B | Negara |
|---|---|---|---|
| 4.7411 | -67.21% |
US
|
|
| 3.0143 | -79.15% |
US
|
|
| 31.051 | 114.75% |
US
|
|
| - | - |
CN
|
|
| 6.6641 | -53.91% |
US
|
